New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1...

This currently recruiting study will support FDA submission of Tandem’s Control-IQ hybrid closed loop for children six years of age or older

The first ever “Closed Loop Showcase”; Ascensia’s diabetes coaching and bundled program; excitement for UnderMyFork app

The diaTribe team was in Barcelona for the 55 th Annual Meeting of the European Association for the Study of Diabetes. Check out our biggest highlights from the...

Available now to California residents, Steady Health offers remote, full-service care for type 1 or type 2 diabetes from a team of endocrinologists, nurses and care...

The diaTribe Foundation’s sixth annual “Solvable Problems in Diabetes” in Barcelona brought together more than 140 leaders to discuss challenges and opportunities in...

Control-IQ the first AID system with automatic correction boluses and no fingersticks CGM (Dexcom G6); cleared for those ages 14 and older; launch in January 2020

Michael writes about his diagnosis with type 2 diabetes, and how he used a CGM to put his type 2 diabetes into remission

A trial in Boston is enrolling 168 individuals ages 65 years and older with type 1 diabetes to investigate the combination of CGM and education to reduce hypoglycemia

diaTribe Community Manager, Cherise Shockley, shares the story of her diabetes diagnosis and how that diagnosis affected her family

New partnerships with Tidepool Loop, plus two new models of virtual clinical care

The tool for people with diabetes to use with their healthcare professionals will launch in early 2020, extending CGM further! Features include fully disposable...

Approved in the US in 2018, the system stops insulin delivery when low blood sugar is predicted

What I've Learned From 70,000 Hours Wearing CGM - A Video Presentation at Thriveabetes 2019

FDA approves WellDoc’s BlueStar app (24/7 diabetes management coaching and support) for use in type 1 diabetes. BlueStar insights also now incorporate data from Dexcom...

This study, now recruiting 350 participants, will examine the safety of the MiniMed 780G Advanced Hybrid Closed Loop System in people with type 1 diabetes (7+ Years)

Omada Health and Abbott partner to bring FreeStyle Libre to Omada Health’s digital coaching program for people with type 2 diabetes

As 2019 comes to an end, we reflect on a year of hope and growth, with immense gratitude for our community. In 2020 we will continue to focus on helping people with...

The automated insulin delivery system with Dexcom’s G6 aims to launch in the US by the end of the year for those ages 14+; first system with auto boluses and no...

A few weeks ago, Kelly experienced severe hypoglycemia (she left her RileyLink in her basement by accident!) – lucky for her, she had just picked up a new emergency...